Skip to main content
. 2022 Jun 14;10(6):1410. doi: 10.3390/biomedicines10061410

Figure 4.

Figure 4

Mechanism of action of CAR T cell therapy. The T cell chimeric antigen receptor binds the target antigen on the tumor cell. This will subsequently allow T cells to mediate anti-tumor effects through the perforin and granzyme axis. Cytokines, such as IL-2, TNF-alpha, and IFN-gamma, promote T cell activation and proliferation.